TokenPost topic
Biotech
5 TokenPost stories are tagged Biotech. The newest appear first.
Latest Biotech stories
- Sunshine Biopharma Announces $6 Million Public Offering Pricing
The offering includes 10.9 million common units, with expected gross proceeds of about $6 million.
· Business
- X4 Pharmaceuticals Enters $150 Million Senior Secured Loan Facility
The agreement with K2 HealthVentures replaces X4’s previous loan facility and includes an $80 million tranche funded at closing.
· Business
- Ascendis Pharma Reports Strong Phase 3 Durability Data for Yorvipath
Ascendis Pharma reported long-term Phase 3 data showing Yorvipath sustained biochemical control and reduced supplement reliance in hypoparathyroidism patients over 3.5 years.
· Business
- Genmab Highlights Epcoritamab Expansion, Advances AI-Driven Oncology Strategy
Genmab showcased epcoritamab’s expanded potential across lymphomas and unveiled AI-driven R&D initiatives at major oncology conferences to support pipeline growth.
· Business
- Incyte Reports Positive Phase 3 Data for Tafasitamab Combo in High-Risk Lymphoma
Incyte announced Phase 3 results showing its tafasitamab plus lenalidomide regimen significantly improved progression-free survival in high-risk lymphoma patients.
· Business